Skip to content

Cognition Therapeutics Inc

CGTX· NasdaqCore metricsCIK 1455365

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · +0.38%
Market cap
$64.52M
95.1M shares
Filings
303
—
—
—
-$4.15M
Q3 2026N/M FY25 yoy
-$7.38M
Q3 2026N/M FY25 yoy
-$11.87M
Q3 2026derivedN/M FY24 yoy
-$0.04
Q3 2026N/M FY25 yoy
$30.76M
Q3 2026+47.2% FY25 yoy
$64.52M
—
—
2.2×
—
—

FY2025 figures · derived

Price

$0.678461.23%$1.0716past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

-$27.00KFY 2023
$0.00-$1.75M0FY 2020FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$27,000reported
FY 20222022-12-31$28,000reported
FY 20212021-12-31$893,000reported
FY 20202020-12-31$1,751,000reported

Biological products, except diagnostic substances

Cognition Therapeutics Inc is the 120th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cognition Therapeutics Inc · CIK 1455365 · Engraved from SEC EDGAR